Substantial efforts have been made to study the effect of p53 expression and/or TP53 mutation status on prognosis for patients with cancer, but the results remain controversial for decades in patients with ESCC 7, 8. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.